Sunshine Biopharma Inc

Research Sunshine Biopharma Inc (SBFM) on Bullrun: market cap USD 3.41M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerSBFM
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryDrug Manufacturers-Specialty & Generic
• CurrencyUSD
• Market capUSD 3.41M
• Financial periodFY2025
• RevenueUSD 36.31M
• Revenue growth4.1%
• Net income-USD 5.98M
• Free cash flow-USD 5.51M
• Gross margin33.8%

Valuation Snapshot

latest market cap is USD 3.41M.

About Sunshine Biopharma Inc

Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules;

Frequently asked questions

What is Sunshine Biopharma Inc's market cap?

Sunshine Biopharma Inc's market capitalization is USD 3.41M.

What does Sunshine Biopharma Inc do?

Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada.